Stockscreener 앱 받기
28.67
3.40%
-1.01
시간 외 거래:
28.53
-0.14
-0.49%
전일 마감가:
$29.68
열려 있는:
$29.83
하루 거래량:
14.96M
Relative Volume:
0.82
시가총액:
$6.53B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
41.55
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
-0.76%
1개월 성능:
-16.44%
6개월 성능:
-51.14%
1년 성능:
-9.10%
1일 변동 폭
$28.32
$29.98
1주일 범위
$28.32
$30.99
52주 변동 폭
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
28.67 | 6.76B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
121.93 | 55.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.69 | 53.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.31 | 46.40B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.21 | 37.32B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
467.30 | 20.53B | 3.13B | 1.27B | 1.12B | 26.39 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 개시 | Evercore ISI | In-line |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers: It's Time To Get Aggressive (NYSE:HIMS) - Seeking Alpha
Surging Q3 Revenue And Cash Pile Could Be A Game Changer For Hims & Hers Health (HIMS) - Yahoo Finance
Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees - Yahoo Finance Singapore
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
HIMS Stock Sees Bearish Sentiment Amidst Increased Volatility - GuruFocus
Looking At Hims & Hers Health's Recent Unusual Options Activity - Benzinga
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? - Yahoo Finance
Noteworthy Monday Option Activity: SKYT, CLOV, HIMS - Nasdaq
Kelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch - GlobeNewswire Inc.
Hims & Hers Stock Approaches a Pivotal Juncture - AD HOC NEWS
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care - Nasdaq
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Finviz
Assessing Hims & Hers Health (HIMS) Valuation After Recent Share Price Volatility - Yahoo Finance
Telehealth Stock Popular With Bulls Despite Underperformance - Schaeffer's Investment Research
Hims & Hers Health: The Reset Nobody Expected (NYSE:HIMS) - Seeking Alpha
Y Intercept Hong Kong Ltd Grows Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
A Profitable Company Under Siege: The Curious Case of Hims & Hers - AD HOC NEWS
End Of Novo Nordisk GLP-1 Deal Could Be A Game Changer For Hims & Hers Health (HIMS) - Sahm
Peering Into Hims & Hers Health Inc's Recent Short Interest - Sahm
Lobbying Update: $330,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Healthcare Stocks To Keep An Eye OnJanuary 23rd - MarketBeat
Steadview Capital Management LLC Purchases 311,845 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
TipRanksXAI Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $31 - Futubull
183,304 Shares in Hims & Hers Health, Inc. $HIMS Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)
How (HIMS) Movements Inform Risk Allocation Models - Stock Traders Daily
What are the hidden costs of weight loss for Americans? - leader-call.com
Healthcare Stocks To ConsiderJanuary 22nd - MarketBeat
HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling? - Yahoo Finance
Why Hims & Hers Stock Slipped Today - AOL.com
QRG Capital Management Inc. Decreases Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Emerald Advisers LLC Acquires New Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Okupe, CFO of Hims & Hers, sells $275k in HIMS stock By Investing.com - Investing.com South Africa
Okupe, CFO of Hims & Hers, sells $275k in HIMS stock - Investing.com
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 9,067 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Stock Price Down 6.2%Here's Why - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Decline - Quiver Quantitative
Best Healthcare Stocks To ConsiderJanuary 5th - MarketBeat
Hims & Hers Health (NYSE:HIMS) Downgraded to "Strong Sell" Rating by Zacks Research - MarketBeat
Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
Hims & Hers Health Stock Outlook: Modeling a 95% Upside Case - TIKR.com
Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets - MSN
Hims And Hers Wegovy Talks Could Reshape Growth And Subscriber Economics - simplywall.st
2 Top Stocks to Double Up On Right Now - Yahoo Finance
Why Hims & Hers Health (HIMS) Stock Is Down Today - Finviz
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Hims & Hers Expands Platform-Led Access to Digital Healthcare - The Globe and Mail
Published on: 2026-01-18 05:20:30 - baoquankhu1.vn
Portfolio Recap: Does SKLZ stock benefit from AI growthJuly 2025 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Market Review: Is Hims Hers Health Inc a top pick in the sectorMarket Risk Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.84%
0.58%
자본화:
|
볼륨(24시간):